USPTO serial 79435264
Reviewed by CopyMark Law Group
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Elizabeth Lee D'Amore
Elizabeth Lee D'Amore Lucas & Mercanti, LLP100 South Jefferson RoadSuite 202Whippany, NJ 07981| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable graphical user interface software for aggregating, integrating, and analyzing clinical, analytical, and imaging data in the field of kidney disease and disorders, and for visualizing patient-specific nephrological parameters, and supporting clinical decision-making by healthcare professionals; Downloadable interactive computer software for aggregating, integrating, and analyzing clinical, analytical, and imaging data in the field of kidney disease and disorders, and for visualizing patient-specific specific nephrological parameters, and supporting clinical decision-making by healthcare professionals; Software as a Medical Device (SaMD), downloadable, for analyzing clinical, analytical, and imaging data relating to patient specific nephrological parameters; all the foregoing for use in hospital and clinical treatment settings, and not for use in medical practice administration, software for patient portals, patient communications, medical billing, appointment scheduling, marketing, practice management, revenue cycle management, medication management, or administrative functions for healthcare providers | ACTIVE | — |
| 042 | Software as a Service (SAAS) services featuring software for aggregating, integrating and analyzing clinical, analytical, and imaging data in the field of kidney disease and disorders, and for visualizing and prioritizing patient specific nephrological parameters to support clinical evaluation and medical decision-making by healthcare professionals; software as a service (SaaS) services featuring software for using machine learning, deep learning and deep neural networks for aggregating, integrating, and analyzing clinical, analytical, and imaging data in the field of kidney disease and disorders, and for visualizing and prioritizing patient specific nephrological parameters to support clinical evaluation and medical decision-making by healthcare professionals; providing temporary use of online non-downloadable computer software for generating clinical decision-support outputs and audit information based on nephrological parameters; all the foregoing for use in hospital and clinical treatment settings, and not for use in medical practice administration, software for patient portals, patient communications, medical billing, appointment scheduling, marketing, practice management, revenue cycle management, medication management, or administrative functions for healthcare providers | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 13, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 13, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 8, 2026 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 7, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 23, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 23, 2026 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 13, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 13, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 13, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 13, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 13, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 14, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 14, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 14, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 5, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 17, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 17, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 11, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 10, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 3, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 25, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 25, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 23, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |